620 related articles for article (PubMed ID: 9767056)
21. T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii.
Denkers EY
Microbes Infect; 1999 Jul; 1(9):699-708. PubMed ID: 10611747
[TBL] [Abstract][Full Text] [Related]
22. Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii.
Cai G; Radzanowski T; Villegas EN; Kastelein R; Hunter CA
J Immunol; 2000 Sep; 165(5):2619-27. PubMed ID: 10946290
[TBL] [Abstract][Full Text] [Related]
23. Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages.
Lüder CG; Algner M; Lang C; Bleicher N; Gross U
Int J Parasitol; 2003 Jul; 33(8):833-44. PubMed ID: 12865083
[TBL] [Abstract][Full Text] [Related]
24. Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice.
Chardès T; Velge-Roussel F; Mevelec P; Mevelec MN; Buzoni-Gatel D; Bout D
Immunology; 1993 Mar; 78(3):421-9. PubMed ID: 8478024
[TBL] [Abstract][Full Text] [Related]
25. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.
Gazzinelli RT; Oswald IP; James SL; Sher A
J Immunol; 1992 Mar; 148(6):1792-6. PubMed ID: 1541819
[TBL] [Abstract][Full Text] [Related]
26. The role of IFN-γ-mediated host immune responses in monitoring and the elimination of Toxoplasma gondii infection.
Ihara F; Yamamoto M
Int Immunol; 2024 Apr; 36(5):199-210. PubMed ID: 38175650
[TBL] [Abstract][Full Text] [Related]
27. Roles of NKT cells in resistance against infection with Toxoplasma gondii and in expression of heat shock protein 65 in the host macrophages.
Nakano Y; Hisaeda H; Sakai T; Ishikawa H; Zhang M; Maekawa Y; Zhang T; Takashima M; Nishitani M; Good RA; Himeno K
Microbes Infect; 2002 Jan; 4(1):1-11. PubMed ID: 11825769
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii.
Lüder CG; Lang T; Beuerle B; Gross U
Clin Exp Immunol; 1998 May; 112(2):308-16. PubMed ID: 9649196
[TBL] [Abstract][Full Text] [Related]
29. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
[TBL] [Abstract][Full Text] [Related]
30. Functional and quantitative analysis of splenic T cell immune responses following oral toxoplasma gondii infection in mice.
Lee YH; Channon JY; Matsuura T; Schwartzman JD; Shin DW; Kasper LH
Exp Parasitol; 1999 Mar; 91(3):212-21. PubMed ID: 10072323
[TBL] [Abstract][Full Text] [Related]
31. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.
Chen J; Li ZY; Petersen E; Liu WG; Zhu XQ
Exp Parasitol; 2016 Mar; 162():18-23. PubMed ID: 26706605
[TBL] [Abstract][Full Text] [Related]
32. Effects of cold stress on spleen cell proliferation and cytokine production during chronic Toxoplasma gondii infection.
Aviles H; Johnson MT; Monroy FP
Neuroimmunomodulation; 2004; 11(2):93-102. PubMed ID: 14758055
[TBL] [Abstract][Full Text] [Related]
33. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii.
Denkers EY
FEMS Immunol Med Microbiol; 2003 Dec; 39(3):193-203. PubMed ID: 14642303
[TBL] [Abstract][Full Text] [Related]
34.
Bando H; Sakaguchi N; Lee Y; Pradipta A; Ma JS; Tanaka S; Lai DH; Liu J; Lun ZR; Nishikawa Y; Sasai M; Yamamoto M
Front Immunol; 2018; 9():2073. PubMed ID: 30283439
[No Abstract] [Full Text] [Related]
35. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches.
Prandota J
Am J Ther; 2007; 14(1):63-105. PubMed ID: 17303977
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii.
Hunter CA; Bermudez L; Beernink H; Waegell W; Remington JS
Eur J Immunol; 1995 Apr; 25(4):994-1000. PubMed ID: 7737303
[TBL] [Abstract][Full Text] [Related]
37. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.
Hunter CA; Subauste CS; Van Cleave VH; Remington JS
Infect Immun; 1994 Jul; 62(7):2818-24. PubMed ID: 7911785
[TBL] [Abstract][Full Text] [Related]
38. Induction and regulation of host cell-mediated immunity by Toxoplasma gondii.
Sher A; Denkers EY; Gazzinelli RT
Ciba Found Symp; 1995; 195():95-104; discussion 104-9. PubMed ID: 8724832
[TBL] [Abstract][Full Text] [Related]
39. The role of IL-12 in stimulating NK cells against Toxoplasma gondii infection: a mini-review.
Mahmoudzadeh S; Nozad Charoudeh H; Marques CS; Bahadory S; Ahmadpour E
Parasitol Res; 2021 Jul; 120(7):2303-2309. PubMed ID: 34110502
[TBL] [Abstract][Full Text] [Related]
40. Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain.
Scharton-Kersten T; Caspar P; Sher A; Denkers EY
Exp Parasitol; 1996 Nov; 84(2):102-14. PubMed ID: 8932760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
